LABORATORY NEWS
-
Abbott's Cologuard Plus® Receives CE Mark For Colorectal Cancer Screening In Europe
Abbott, a global healthcare leader, announced today that the Cologuard Plus® test has received CE Mark under the European Union's In Vitro Diagnostic Medical Devices Regulation (IVDR), marking an important step toward making the noninvasive colorectal cancer screening test available in Europe.
- Revvity Launches Signals LabGistics Solution To Connect And Orchestrate Scientific Workflows
- Hologic And Inpeco Announce Co-Marketing Partnership To Advance Molecular Laboratory Automation
- Metabolic Supply Group Brings Lab Testing And Physician Oversight To Metabolic And Peptide Care
- Novel Biopump Delivers Ultra-Low Shear Flow
ARCHIVED NEWSLETTER
- 10.06.26 -- QIAGEN Launches QIAmini To Automate Small-Batch Sample Preparation
- 09.22.26 -- Sakura Finetek Europe Launches Sakura Pathology Network
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis